Anti-CD3 antibodies for type 1 diabetes: beyond expectations.

作者信息

Bach Jean-François

机构信息

Université Paris Descartes, Paris, France.

出版信息

Lancet. 2011 Aug 6;378(9790):459-60. doi: 10.1016/S0140-6736(11)60980-X. Epub 2011 Jun 28.

DOI:10.1016/S0140-6736(11)60980-X

PMID:21719098

Abstract

摘要

相似文献

[1]

Anti-CD3 antibodies for type 1 diabetes: beyond expectations.

Lancet. 2011-8-6

[2]

Teplizumab for treatment of type 1 diabetes (Protégé study): 1-year results from a randomised, placebo-controlled trial.

Lancet. 2011-6-28

[3]

[One step towards restoration of self-tolerance in human autoimmune diseases].

Med Sci (Paris). 2007-2

[4]

The use of CD3-specific antibodies in autoimmune diabetes: a step toward the induction of immune tolerance in the clinic.

Handb Exp Pharmacol. 2008

[5]

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes.

Diabetes. 2005-6

[6]

[Anti-CD3 monoclonal antibodies: a new step towards therapy in new-onset type 1 diabetes].

Med Sci (Paris). 2006-1

[7]

Can we change the course of beta-cell destruction in type 1 diabetes?

N Engl J Med. 2002-5-30

[8]

Prolactin: An Effective Partner for Anti-CD3 in Treating Type 1 Diabetes.

Endocrinology. 2016-1

[9]

[CD3-specific antibody-induced T-cell apoptosis and apoptotic cell uptake lead to CD3-specific antibody-induced tolerance].

Med Sci (Paris). 2009-4

[10]

Type 1 diabetes--does suppressing T cells increase insulin?

N Engl J Med. 2005-6-23

引用本文的文献

[1]

Therapy concepts in type 1 diabetes mellitus treatment: disease modifying versus curative approaches.

J Mol Med (Berl). 2024-12

[2]

Increase in the Expression of Glucose Transporter 2 (GLUT2) on the Peripheral Blood Insulin-Producing Cells (PB-IPC) in Type 1 Diabetic Patients after Receiving Stem Cell Educator Therapy.

Int J Mol Sci. 2024-7-30

[3]

The immunology of type 1 diabetes.

Nat Rev Immunol. 2024-6

[4]

Resolvin D1 Decreases Severity of Streptozotocin-Induced Type 1 Diabetes Mellitus by Enhancing BDNF Levels, Reducing Oxidative Stress, and Suppressing Inflammation.

Int J Mol Sci. 2021-2-3

[5]

Immune Modulation of Platelet-Derived Mitochondria on Memory CD4 T Cells in Humans.

Int J Mol Sci. 2020-8-31

[6]

Remission of autoimmune diabetes by anti-TCR combination therapies with anti-IL-17A or/and anti-IL-6 in the IDDM rat model of type 1 diabetes.

BMC Med. 2020-2-28

[7]

Immunotherapy for Parkinson's disease.

Neurobiol Dis. 2020-4

[8]

PAHSAs attenuate immune responses and promote β cell survival in autoimmune diabetic mice.

J Clin Invest. 2019-8-5

[9]

The Development of Immunotherapy Strategies for the Treatment of Type 1 Diabetes.

Front Med (Lausanne). 2018-10-9

[10]

T Cell-Mediated Chronic Inflammatory Diseases Are Candidates for Therapeutic Tolerance Induction with Heat Shock Proteins.

Front Immunol. 2017-10-26

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

新学期，新优惠

Anti-CD3 antibodies for type 1 diabetes: beyond expectations.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

文献AI研究员

用中文搜PubMed

推荐工具

Suppr 超能文献

相似文献

引用本文的文献